Back to today’s briefing

Story perspectives

Bain Capital to Acquire Mitsubishi Tanabe for $3.3 Billion

2/7/2025

41 9

Summary

Story summary

Bain Capital plans to acquire Mitsubishi Tanabe Pharma for 510 billion yen ($3.3 billion), creating an independent entity.
The acquisition aims to boost Tanabe's drug development, addressing unmet medical needs in Japan's life sciences.
Mitsubishi Chemical Group will utilize the proceeds to lower debt and reinvest in its core chemicals sector.
The deal is anticipated to finalize in the third quarter of 2025, subject to regulatory approval.

1 of 1

Story summary

Bain Capital plans to acquire Mitsubishi Tanabe Pharma for 510 billion yen ($3.3 billion), creating an independent entity.
The acquisition aims to boost Tanabe's drug development, addressing unmet medical needs in Japan's life sciences.
Mitsubishi Chemical Group will utilize the proceeds to lower debt and reinvest in its core chemicals sector.
The deal is anticipated to finalize in the third quarter of 2025, subject to regulatory approval.